Large-scale testing (Phase 3)Study completedNCT01105507
What this trial is testing
The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada
Who this might be right for
Cryopyrin Associated Periodic Syndrome
Novartis Pharmaceuticals 4